|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
affects export multiple interactions |
EXP |
ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog Glutathione promotes the reaction [ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog] |
CTD |
PMID:15766272 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
increases expression decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of ABL1 mRNA 4-Nitroquinoline-1-oxide results in decreased expression of ABL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
|
|
G |
ACSL1 |
acyl-CoA synthetase long chain family member 1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of ACSL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
|
|
G |
ACSL6 |
acyl-CoA synthetase long chain family member 6 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of ACSL6 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:131,949,973...132,012,213
Ensembl chr 5:131,949,973...132,012,243
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased phosphorylation of AKT1 protein |
CTD |
PMID:37406968 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
BCL2A1 |
BCL2 related protein A1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BCL2A1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
G |
BSCL2 |
BSCL2 lipid droplet biogenesis associated, seipin |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BSCL2 mRNA |
CTD |
PMID:22003191 |
|
NCBI chr11:62,690,262...62,709,537
Ensembl chr11:62,689,289...62,709,845
|
|
G |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BUB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL4 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
increases expression decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL5 mRNA 4-Nitroquinoline-1-oxide results in decreased expression of CCL5 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL7 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNA2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions increases expression |
EXP ISO |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA] 4-Nitroquinoline-1-oxide results in increased expression of CCND1 mRNA |
CTD |
PMID:20043093 PMID:27148699 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE2 |
cyclin E2 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNE2 mRNA 4-Nitroquinoline-1-oxide results in increased expression of CCNE2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CD59 |
CD59 molecule (CD59 blood group) |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein |
CTD |
PMID:19965957 PMID:20202993 |
|
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
|
|
G |
CDC25C |
cell division cycle 25C |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CDC25C mRNA 4-Nitroquinoline-1-oxide results in increased expression of CDC25C mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
|
|
G |
CDC7 |
cell division cycle 7 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CDC7 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:91,500,851...91,525,764
Ensembl chr 1:91,500,851...91,525,764
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CPT1B |
carnitine palmitoyltransferase 1B |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CPT1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
|
|
G |
CRYAB |
crystallin alpha B |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide co-treated with Arecoline] results in increased expression of CRYAB protein |
CTD |
PMID:19840781 |
|
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
|
|
G |
CRYZ |
crystallin zeta |
increases activity multiple interactions |
ISO |
4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein] |
CTD |
PMID:12566915 |
|
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
|
|
G |
CSF2 |
colony stimulating factor 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CSF2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CTSD |
cathepsin D |
multiple interactions increases activity |
ISO |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CTSD protein] |
CTD |
PMID:23499697 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CTTN |
cortactin |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CTTN mRNA; 4-Nitroquinoline-1-oxide results in increased expression of CTTN protein |
CTD |
PMID:27148699 |
|
NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL1 mRNA |
CTD |
PMID:22561872 PMID:27148699 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CXCL10 mRNA 4-Nitroquinoline-1-oxide results in increased expression of CXCL10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL11 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL5 mRNA |
CTD |
PMID:27148699 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL9 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCR3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
|
|
G |
CYB5A |
cytochrome b5 type A |
multiple interactions increases activity |
ISO |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein] |
CTD |
PMID:23499697 |
|
NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,973
|
|
G |
E2F3 |
E2F transcription factor 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of E2F3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
|
|
G |
EPCAM |
epithelial cell adhesion molecule |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of EPCAM mRNA |
CTD |
PMID:27148699 |
|
NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] |
CTD |
PMID:32942007 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GPX4 |
glutathione peroxidase 4 |
increases expression multiple interactions |
EXP |
4-Nitroquinoline-1-oxide results in increased expression of GPX4 protein 4-Nitroquinoline-1-oxide promotes the reaction [Glucose results in increased expression of GPX4 protein] |
CTD |
PMID:32942007 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
G |
H2AX |
H2A.X variant histone |
increases expression increases phosphorylation |
EXP |
4-Nitroquinoline-1-oxide results in increased expression of H2AX protein 4-Nitroquinoline-1-oxide results in increased phosphorylation of H2AX protein |
CTD |
PMID:32087850 PMID:34510228 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HMOX1 |
heme oxygenase 1 |
affects expression multiple interactions |
EXP |
4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein 4-Nitroquinoline-1-oxide inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; [4-Nitroquinoline-1-oxide results in increased susceptibility to Glucose] which results in increased expression of HMOX1 protein; Glucose inhibits the reaction [4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein] |
CTD |
PMID:32942007 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
EXP |
4-Nitroquinoline-1-oxide results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:26362870 PMID:28454271 |
|
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
multiple interactions |
EXP |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA; [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA]; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] |
CTD |
PMID:20043093 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide co-treated with Arecoline] results in increased expression of HSPB1 protein |
CTD |
PMID:19840781 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
|
|
G |
IFNB1 |
interferon beta 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IFNB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IFNG mRNA 4-Nitroquinoline-1-oxide results in increased expression of IFNG mRNA |
CTD |
PMID:22561872 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL12A mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IL12B mRNA 4-Nitroquinoline-1-oxide results in increased expression of IL12B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL19 |
interleukin 19 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL19 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:206,770,773...206,842,981
Ensembl chr 1:206,770,764...206,842,981
|
|
G |
IL1B |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL1B mRNA [Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of IL1B mRNA geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of IL1B protein] |
CTD |
PMID:22561872 PMID:28397014 PMID:37406968 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL23A |
interleukin 23 subunit alpha |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IL23A mRNA 4-Nitroquinoline-1-oxide results in increased expression of IL23A mRNA |
CTD |
PMID:22561872 |
|
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IL24 |
interleukin 24 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL24 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
|
|
G |
IL6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL6 mRNA [Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of IL6 mRNA |
CTD |
PMID:22561872 PMID:37406968 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of JUN mRNA |
CTD |
PMID:37406968 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAPK6 |
mitogen-activated protein kinase 6 |
multiple interactions increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of and results in increased phosphorylation of MAPK6 protein 4-Nitroquinoline-1-oxide results in increased expression of MAPK6 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr15:51,971,825...52,067,375
Ensembl chr15:51,952,106...52,067,375
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
multiple interactions increases expression |
ISO |
Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein] |
CTD |
PMID:37406968 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MMP10 |
matrix metallopeptidase 10 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
|
|
G |
MMP12 |
matrix metallopeptidase 12 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of MMP12 mRNA 4-Nitroquinoline-1-oxide results in increased expression of MMP12 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of MMP13 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP9 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO |
ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein]; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein] |
CTD |
PMID:12566915 PMID:28397014 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases reduction multiple interactions decreases activity decreases response to substance |
EXP ISO |
NQO1 protein results in increased reduction of 4-Nitroquinoline-1-oxide geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in decreased activity of NQO1 protein] NQO1 protein results in decreased susceptibility to 4-Nitroquinoline-1-oxide |
CTD |
PMID:9310146 PMID:23499697 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
OSM |
oncostatin M |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of OSM mRNA |
CTD |
PMID:22561872 |
|
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
|
|
G |
OSMR |
oncostatin M receptor |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of OSMR mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:38,846,012...38,945,579
Ensembl chr 5:38,845,858...38,945,596
|
|
G |
PIGA |
phosphatidylinositol glycan anchor biosynthesis class A |
multiple interactions increases mutagenesis |
ISO |
4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein 4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA; 4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene |
CTD |
PMID:19965957 PMID:20202993 PMID:22923490 PMID:29362862 |
|
NCBI chr X:15,319,451...15,335,554
Ensembl chr X:15,319,452...15,335,554
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased phosphorylation of PIK3R1 protein |
CTD |
PMID:37406968 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
POR |
cytochrome p450 oxidoreductase |
multiple interactions increases activity |
ISO |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of POR protein] |
CTD |
PMID:23499697 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
G |
PPBP |
pro-platelet basic protein |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of PPBP mRNA 4-Nitroquinoline-1-oxide results in increased expression of PPBP mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases response to substance |
EXP ISO |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein] PTGS2 gene mutant form results in decreased susceptibility to 4-Nitroquinoline-1-oxide Zinc deficiency inhibits the reaction [PTGS2 gene mutant form results in decreased susceptibility to 4-Nitroquinoline-1-oxide] 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 mRNA; 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein |
CTD |
PMID:20043093 PMID:20857495 PMID:22561872 PMID:28397014 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTHLH |
parathyroid hormone like hormone |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of PTHLH mRNA |
CTD |
PMID:27148699 |
|
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
affects localization multiple interactions |
ISO |
4-Nitroquinoline-1-oxide affects the localization of RELA protein 4-Nitroquinoline-1-oxide results in increased expression of and affects the localization of RELA protein; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of and affects the localization of RELA protein] |
CTD |
PMID:22561872 PMID:28397014 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of RRM2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
|
|
G |
SRXN1 |
sulfiredoxin 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 |
|
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
|
|
G |
TK1 |
thymidine kinase 1 |
increases mutagenesis |
EXP |
4-Nitroquinoline-1-oxide results in increased mutagenesis of TK1 gene |
CTD |
PMID:28454271 PMID:32087850 |
|
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of TNF protein] |
CTD |
PMID:28397014 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TP53 |
tumor protein p53 |
affects response to substance increases expression decreases expression |
ISO EXP |
TRP53 protein affects the susceptibility to 4-Nitroquinoline-1-oxide 4-Nitroquinoline-1-oxide results in increased expression of TP53 protein 4-Nitroquinoline-1-oxide results in decreased expression of TP53 protein |
CTD |
PMID:16543248 PMID:20599846 PMID:32087850 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRAF1 |
TNF receptor associated factor 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of TRAF1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
|
|
G |
WEE1 |
WEE1 G2 checkpoint kinase |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of WEE1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr11:9,573,670...9,589,985
Ensembl chr11:9,573,670...9,593,457
|
|
G |
XCL1 |
X-C motif chemokine ligand 1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of XCL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:168,576,605...168,582,069
Ensembl chr 1:168,576,605...168,582,069
|
|